BDP1 and ovarian serous adenocarcinoma: Only the TFIIIB subunit BDP1 exhibited significantly decreased expression in serous ovarian cancer as the stage increased (F = 8.06; Pr(>F) = 3.66 × 10−4) (Figure 3A).